Old Web
Antenatal Treatment with Intravenous Immunoglobulin to Prevent Gestational Alloimmune Liver Disease: Comparative Effectiveness of 14-Week versus 18-Week Initiation
2017
Background: Antenatal therapy with high-dose intravenous immunoglobulin (IVIG) may prevent gestational alloimmune liver disease (GALD). Objectiv
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
22
References
15
Citations
NaN
KQI